Inventors
Chiungkuang Chen, Aishwarya Kundu, Sreenivasu Mudumba, Masaaki Kageyama, Akira Nonoyama, Atsushi Yoshida, Yasuo Yanagi, Chui Ming Gemmy Cheung, Tokiyoshi Matsushita, Chie Shintani, Merry Gunawan, Erika Kimura, Ming Chuan, Richard Yu
Assignees
- Santen Pharmaceutical Co., Ltd.
- Singapore Health Services Pte Ltd
Abstract
The present disclosure relates to bispecific binding molecules against human vascular endothelial growth factor (VEGF/VEGF-A) and against human angioprotein-2 (ANG-2), including protein sequences, methods for their production, pharmaceutical compositions containing the bispecific binding molecules, and therapeutic and diagnostic uses thereof.
CovalX Technology Used
High-Mass MALDI MS
Crosslinking Kits
HM4
